Operating Margin % is calculated as Operating Income divided by its Revenue. Tilray Brands's Operating Income for the
three
months ended in Feb. 2026 was C$-27 Mil. Tilray Brands's Revenue for the
three
months ended in Feb. 2026 was C$282 Mil. Therefore, Tilray Brands's Operating Margin % for the quarter that ended in Feb. 2026 was -9.61%.
The historical rank and industry rank for Tilray Brands's Operating Margin % or its related term are showing as below:
TSX:TLRY'
s Operating Margin % Range Over the Past 10 Years
Min: -37.12 Med: -13.83 Max: 10.32
Current: -7.39
TSX:TLRY's Operating Margin % is ranked worse than 77.8% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs TSX:TLRY: -7.39
Tilray Brands's 5-Year Average Operating Margin % Growth Rate was -0.50% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Tilray Brands Operating Margin % Related Terms
Tilray Brands Operating Margin % Historical Data
* Premium members only.
The historical data trend for Tilray Brands's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:TLRY vs IRWD, BIOA, ESPR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tilray Brands Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Tilray Brands's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Tilray Brands's Operating Margin % for the fiscal year that ended in May. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tilray Brands (TSX:TLRY) has a Operating Margin % of -9.61% as of Feb. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #743 out of 955 companies in the Drug Manufacturers industry, placing it in the top 77.8%.
Is Tilray Brands' Operating Margin % too high?
Tilray Brands' current Operating Margin % is -9.61%. Based on the distribution chart, Tilray Brands ranks #743 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Operating Margin % compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #743 out of 955 companies for Operating Margin %. This places Tilray Brands in the lower half of its industry. The industry median Operating Margin % is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current Operating Margin % is -9.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.50, compared to a current price of C$6.34 — trading 63.8% below its estimated fair value. The current Operating Margin % is -9.61%. Tilray Brands' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current Operating Margin % is -9.61% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tilray Brands (TSX:TLRY) Overvalued in 2026?
Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued.
The current stock price of C$6.34 is trading 63.8% below its estimated GF Value™ of C$17.50.
GuruFocus considers Tilray Brands to be Possible Value Trap.
Key valuation signals for TSX:TLRY:
Operating Margin %: -9.61%
GF Value™: C$17.50 vs. price of C$6.34 (63.8% below fair value)
No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
59GF Score
Get the complete analysis for TSX:TLRY
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TLRY has been successfully added to your 
